Author:
Bernusso Vanessa A.,Machado-Neto João A.,Pericole Fernando V.,Vieira Karla P.,Duarte Adriana S.S.,Traina Fabiola,Hansen Marc D.,Olalla Saad Sara T.,Barcellos Karin S.A.
Funder
National Institute of Science
Technology on Photonics Applied to Cell Biology (INFABIC)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Subject
Cell Biology,Molecular Biology
Reference43 articles.
1. A common phosphotyrosine signature for the Bcr-Abl kinase;Goss;Blood,2006
2. Efficacy and safety of a specific inhibitor of the BCR–ABL tyrosine kinase in chronic myeloid leukemia;Druker;N. Engl. J. Med.,2001
3. Bim and Bad mediate imatinib-induced killing of Bcr/Abl+leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic;Kuroda;Proc. Natl. Acad. Sci. U. S. A.,2006
4. Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia;Kuroda;Cell Death Differ.,2007
5. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms;Kuroda;Br. J. Haematol.,2008
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献